These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17380034)

  • 1. Pharmacological aspects of the effects of tramadol on G-protein coupled receptors.
    Minami K; Uezono Y; Ueta Y
    J Pharmacol Sci; 2007 Mar; 103(3):253-60. PubMed ID: 17380034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the main mechanism of tramadol?
    Minami K; Ogata J; Uezono Y
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):999-1007. PubMed ID: 26292636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent evidences in the pharmacological mechanisms of the tramadol].
    Mimami K
    Masui; 2005 Nov; 54(11):1224-33. PubMed ID: 16296359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gq protein-coupled receptors as targets for anesthetics.
    Minami K; Uezono Y
    Curr Pharm Des; 2006; 12(15):1931-7. PubMed ID: 16724958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of anesthetics on G-protein-coupled receptors].
    Minami K; Uezono Y
    Masui; 2005 Feb; 54(2):118-25. PubMed ID: 15747504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors.
    Minami K; Uezono Y
    J Anesth; 2013 Apr; 27(2):284-92. PubMed ID: 23099434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effects of tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M(3) receptors.
    Shiga Y; Minami K; Shiraishi M; Uezono Y; Murasaki O; Kaibara M; Shigematsu A
    Anesth Analg; 2002 Nov; 95(5):1269-73, table of contents. PubMed ID: 12401609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M1 receptors.
    Shiraishi M; Minami K; Uezono Y; Yanagihara N; Shigematsu A
    J Pharmacol Exp Ther; 2001 Oct; 299(1):255-60. PubMed ID: 11561087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. µ-Opioid receptor activation by tramadol and O-desmethyltramadol (M1).
    Minami K; Sudo Y; Miyano K; Murphy RS; Uezono Y
    J Anesth; 2015 Jun; 29(3):475-479. PubMed ID: 25394761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology of tramadol].
    Dayer P; Desmeules J; Collart L
    Drugs; 1997; 53 Suppl 2():18-24. PubMed ID: 9190321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to the pharmacology of analgesics.
    Raffa RB
    Am J Med; 1996 Jul; 101(1A):40S-46S. PubMed ID: 8764759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1.
    Marincsák R; Tóth BI; Czifra G; Szabó T; Kovács L; Bíró T
    Anesth Analg; 2008 Jun; 106(6):1890-6. PubMed ID: 18499628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity.
    Miyano K; Minami K; Yokoyama T; Ohbuchi K; Yamaguchi T; Murakami S; Shiraishi S; Yamamoto M; Matoba M; Uezono Y
    Anesth Analg; 2015 Apr; 120(4):790-8. PubMed ID: 25642661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine.
    Reimann W; Schneider F
    Eur J Pharmacol; 1998 May; 349(2-3):199-203. PubMed ID: 9671098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tramadol state-dependent memory: involvement of dorsal hippocampal muscarinic acetylcholine receptors.
    Jafari-Sabet M; Jafari-Sabet AR; Dizaji-Ghadim A
    Behav Pharmacol; 2016 Aug; 27(5):470-8. PubMed ID: 27089282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes.
    Ogata J; Minami K; Uezono Y; Okamoto T; Shiraishi M; Shigematsu A; Ueta Y
    Anesth Analg; 2004 May; 98(5):1401-6, table of contents. PubMed ID: 15105221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of opioid analgesics on potential-gated ion channels in the pond snail neurons].
    Vislobokov AI; Savos'kin AL
    Eksp Klin Farmakol; 2000; 63(4):7-12. PubMed ID: 11022297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol.
    Rojas-Corrales MO; Berrocoso E; Micó JA
    Eur J Pharmacol; 2005 Mar; 511(1):21-6. PubMed ID: 15777775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tramadol: basic pharmacology and emerging concepts.
    Reeves RR; Burke RS
    Drugs Today (Barc); 2008 Nov; 44(11):827-36. PubMed ID: 19180260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.